Global update on the susceptibility of human influenza viruses to neuraminidase inhibitors, 2015–2016

Author:

Gubareva Larisa V.,Besselaar Terry G.,Daniels Rod S.,Fry Alicia,Gregory Vicki,Huang Weijuan,Hurt Aeron C.,Jorquera Patricia A.,Lackenby Angie,Leang Sook-Kwan,Lo Janice,Pereyaslov Dmitriy,Rebelo-de-Andrade HelenaORCID,Siqueira Marilda M.,Takashita EmiORCID,Odagiri Takato,Wang Dayan,Zhang Wenqing,Meijer Adam

Funder

British Medical Research Council

Australian Government Department of Health

Ministry of Health, Labour and Welfare, Japan

JSPS KAKENHI

A*STAR-NHMRC

Advanced Molecular Detection (AMD) Program, CDC

Publisher

Elsevier BV

Subject

Virology,Pharmacology

Reference37 articles.

1. Antiviral drug–resistant influenza B viruses carrying H134N substitution in neuraminidase, Laos, February 2016;Baranovich;Emerg. Infect. Dis.,2017

2. Incidence of adamantane resistance among influenza A (H3N2) viruses isolated worldwide from 1994 to 2005: a cause for concern;Bright;Lancet,2005

3. Influenza viruses with B/Yamagata- and B/Victoria-like neuraminidases are differentially affected by mutations that alter antiviral susceptibility;Farrukee;J. Antimicrob. Chemother.,2015

4. The FDA Approves First Generic Version of Widely Used Influenza Drug, Tamiflu;FDA,2016

5. Mutations at the monomer-monomer interface away from the active site of influenza B virus neuraminidase reduces susceptibility to neuraminidase inhibitor drugs;Fujisaki;J. Infect. Chemother.,2013

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3